What smart money is saying about ChemoMetec
CHEMM.CO
No fund has written a full thesis on ChemoMetec in our archive, but 1 fund letter reports a position in it — most recently Kavaljer Quality Focus in July 2026.
Get an email when a fund writes about it
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in ChemoMetec on record in the archive was reported in Q3 2026, across 1 fund letter — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 1 | 0 | 0 |
Fund activity · 1 position · 1 move
- July 2026
“Changes and holdings During the month the fund reduced its holding in Pandora and sold its entire holdings in Bahnhof, in connection with the Telenor bid, and in Nilörngruppen, where the bid went through as expected. We also added to ChemoMetec, Xvivo, BoneSupport, Nederman, ITAB, Proact and Valmet.”
ChemoMetec
Read the letters behind these ChemoMetec positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger